TAKHZYRO 300 mg
TAKHZYRO 300 mg is a medicine authorised by Swissmedic under authorisation number 68178. The authorisation holder is Takeda Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 November 2020 and the authorisation is valid without a time limit. ATC code B06AC05 places the medicine in the group Other hematological agents.
| Authorisation number | 68178 |
|---|---|
| Name | TAKHZYRO 300 mg |
| Full name | TAKHZYRO 300 mg, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | B06AC05 |
| First authorisation | 05 November 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | TAKHZYRO 300 mg, Injektionslösung in einer Fertigspritze | B | 05 November 2020 |
| 2 | TAKHZYRO 150 mg, Injektionslösung in einer Fertigspritze | B | 11 April 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | B06AC05 | 02.99.0. | B |
| 2 | 1 | Fertigspritze(n) | B06AC05 | 02.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is TAKHZYRO 300 mg authorised in Switzerland?
Yes. TAKHZYRO 300 mg is authorised by Swissmedic under authorisation number 68178, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does TAKHZYRO 300 mg have?
TAKHZYRO 300 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of TAKHZYRO 300 mg?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.